Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
基本信息
- 批准号:10385766
- 负责人:
- 金额:$ 46.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
The field of pharmacology has a direct impact on the health and care of the U.S. population. Located at The
Johns Hopkins University School of Medicine, the Department of Pharmacology and Molecular Sciences (DPMS)
is well-positioned to provide superb career training in the broad field of Pharmacology. The training mission of
the Pharmacology and Molecular Sciences (PMS) Training Program is centered on providing trainees with state-
of-the-art research knowledge and professional skills focused on drug design, mechanism of action and the
process of development and translation. Our broad objective is to prepare a diverse pool of budding scientist-
scholars for a variety of pharmacology-related careers. The Program curriculum and activities are specifically
designed to provide training that covers each component of the drug discovery and development pipeline and to
nurture a positive training experience. We accomplish this objective through numerous activities designed to
develop trainee core competencies and preparation for careers in pharmacology. In addition to mentored
laboratory research, our program has four training components: 1) specialized and broad coursework in the
areas of basic and clinical pharmacology, physiology, bioorganic chemistry, drug discovery and biomedical
sciences, 2) collaborative ties to the Lieber Institute for Brain Development (LIBD), which exposes students to a
translational biotech research environment, and the Division of Clinical Pharmacology, which offers training in
the areas of clinical and translational pharmacology, 3) multi-faceted pharmacology-focused career building and
networking activities through our extensive alumni and pharmaceutical career connections and institutional
resources, and 4) multi-faceted pharmacology-related training in the responsible conduct of research and
methods to enhance reproducibility that are ongoing throughout training. With the above plan we arm our trainees
with the requisite knowledge base, technical and professional skills needed to be successful in the broad field of
pharmacology. Our success in achieving these objectives will be measured through validated assessment
instruments covering the courses, training activities, Doctorate Board Oral/Written Exams, and through external
reviews. Importantly, we strive to provide a pathway for our trainees to attain skills that allow them to achieve
work-life balance and to positively impact society in their chosen career paths. The Program intends to recruit
and retain nine new trainees each year who will be supported by this training grant for their first year of training.
In their subsequent years of mentored research, they will be supported by our well-funded and diverse training
faculty. The Program is structured to support appropriate time-to-degree for all trainees (~5 years). We provide
a unique pharmacology-focused career and professional development curriculum and environment that arms
trainees with the skills to adapt to an ever-changing biomedical research landscape and directly facilitates entry
into a broad spectrum of pharmacology-related career paths.
项目摘要
药理学领域对美国人口的健康和护理有直接影响。位于
约翰·霍普金斯大学医学院,药理学与分子科学系(DPMS)
位置很好,可以在药理学领域提供出色的职业培训。训练任务的
药理学和分子科学(PMS)培训计划以向受训者提供州为中心
艺术研究知识和专业技能的重点是药物设计,行动机理和
发展和翻译过程。我们的广泛目标是准备各种各样的新兴科学家 -
各种与药理学有关的职业的学者。计划课程和活动专门
旨在提供涵盖药物发现和开发管道的每个组成部分的培训以及
培养积极的培训经验。我们通过许多旨在的活动来实现这一目标
发展学员的核心能力和药理学职业的准备。除了指导
实验室研究,我们的计划有四个培训组成部分:1)专业和广泛的课程
基础和临床药理学,生理学,生物有机化学,药物发现和生物医学领域
科学,2)与利伯大脑发展研究所(LIBD)的合作关系,该研究所使学生暴露于
转化生物技术研究环境和临床药理学的部门,提供培训
临床和转化药理学领域,3)以药理学为重点的职业大楼和
通过我们广泛的校友和制药职业联系和机构的网络活动
资源和4)在负责任的研究和
提高整个培训过程中正在进行的可重复性的方法。使用上述计划,我们武装学员
凭借必要的知识库,需要在广阔领域取得成功的技术和专业技能
药理。我们在实现这些目标方面的成功将通过经过验证的评估来衡量
涵盖课程,培训活动,博士董事会口试/笔试的仪器以及外部
评论。重要的是,我们努力为学员提供一条途径,以获得使他们能够实现的技能
工作与生活的平衡并积极影响社会在他们选择的职业道路上。该计划打算招募
并保留每年的9名新学员,他们将获得这笔培训赠款的第一年培训。
在随后的指导研究中,我们将得到我们资金丰富且多样化的培训的支持
学院。该计划的结构旨在为所有学员(约5年)提供适当的时间时间。我们提供
以药理学为重点的独特职业和专业发展课程和环境
具有适应不断变化的生物医学研究环境并直接促进进入的学员
进入与药理学有关的职业道路的广泛。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caren L. Freel Meyers其他文献
Caren L. Freel Meyers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caren L. Freel Meyers', 18)}}的其他基金
Targeting DXP synthase in bacterial metabolism
靶向细菌代谢中的 DXP 合酶
- 批准号:
10576858 - 财政年份:2021
- 资助金额:
$ 46.83万 - 项目类别:
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10641824 - 财政年份:2021
- 资助金额:
$ 46.83万 - 项目类别:
Targeting DXP synthase in bacterial metabolism
靶向细菌代谢中的 DXP 合酶
- 批准号:
10372207 - 财政年份:2021
- 资助金额:
$ 46.83万 - 项目类别:
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10470350 - 财政年份:2021
- 资助金额:
$ 46.83万 - 项目类别:
Toward understanding the chemistry and biology of microbial DXP synthase
了解微生物 DXP 合酶的化学和生物学
- 批准号:
10317255 - 财政年份:2021
- 资助金额:
$ 46.83万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10197160 - 财政年份:2020
- 资助金额:
$ 46.83万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10617205 - 财政年份:2020
- 资助金额:
$ 46.83万 - 项目类别:
Pharmacology and Molecular Sciences Training Program: Enhancing Inclusivity Through Universal Design for Learning in Graduate Courses
药理学和分子科学培训计划:通过研究生课程学习的通用设计增强包容性
- 批准号:
10592034 - 财政年份:2020
- 资助金额:
$ 46.83万 - 项目类别:
相似国自然基金
基于定量系统药理学模型和类器官的人促卵泡激素精准用药研究
- 批准号:82373952
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
苯并呋喃-6-酮类化合物TT01f通过调控Jagged1/Notch信号通路改善特发性肺纤维化的药理学机制研究
- 批准号:82304596
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
药物转运蛋白对SOS1-KRAS通路抑制剂BI-1701963药理学影响的研究
- 批准号:82304554
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
低强度超声激励功能化纳米砷烯抗三阴性乳腺癌的药理学机制及可视化研究
- 批准号:82304544
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于最简生理药动学-系统药理学-虚拟临床试验(mPBPK-QSP-VCT)模型的PD-1/PD-L1单抗和VEGF抑制剂联合用药定量药理学研究
- 批准号:82373949
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Refining oxytocin therapy for pain: context is key
完善催产素治疗疼痛的方法:背景是关键
- 批准号:
10595113 - 财政年份:2023
- 资助金额:
$ 46.83万 - 项目类别:
Unraveling how Lipophilic Modulators Alter pLGIC Function via Interactions with the M4 Transmembrane Helix
揭示亲脂性调节剂如何通过与 M4 跨膜螺旋相互作用改变 pLGIC 功能
- 批准号:
10785755 - 财政年份:2023
- 资助金额:
$ 46.83万 - 项目类别:
A full spectrum rational approach to identify antiarrhythmic agents targeting IKs Channels
识别针对 IK 通道的抗心律失常药物的全谱理性方法
- 批准号:
10734513 - 财政年份:2023
- 资助金额:
$ 46.83万 - 项目类别:
Catheter-injectable system for local drug delivery after myocardial infarct
用于心肌梗死后局部给药的导管注射系统
- 批准号:
10722614 - 财政年份:2023
- 资助金额:
$ 46.83万 - 项目类别:
Identification of Genetic Variants that Influence Compulsive Alcohol Intake in Outbred Rats
影响近交系大鼠强迫性饮酒的遗传变异的鉴定
- 批准号:
10585109 - 财政年份:2023
- 资助金额:
$ 46.83万 - 项目类别: